Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - North America

North America

In North America, specifically United States, the Treatment of Cardiovascular Diseases market is expected to see significant growth in revenue.
By 2024, the projected revenue for this market is estimated to reach an impressive US$136.00bn.
Looking ahead, the market is expected to continue expanding at an annual growth rate of 3.36% between 2024 and 2029.
This steady growth will result in a market volume of approximately US$178.00bn by 2029.
In North America, the use of advanced imaging techniques for diagnosing and monitoring cardiovascular diseases is on the rise.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.